HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $454 | -4.2% | 11,874 | -9.7% | 0.04% | -5.4% |
| Q2 2023 | $474 | +33.9% | 13,152 | +41.8% | 0.04% | +42.3% |
| Q1 2023 | $354 | -16.3% | 9,277 | +24.9% | 0.03% | -25.7% |
| Q4 2022 | $423 | -99.9% | 7,427 | -35.4% | 0.04% | -16.7% |
| Q3 2022 | $455,000 | +3.4% | 11,505 | +15.0% | 0.04% | +5.0% |
| Q2 2022 | $440,000 | +42.9% | 10,000 | +29.4% | 0.04% | +300.0% |
| Q1 2022 | $308,000 | +52.5% | 7,726 | +53.7% | 0.01% | +42.9% |
| Q4 2021 | $202,000 | – | 5,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |